Non-alcoholic fatty liver disease (NAFLD) is a chronic liver disease associated with insulin
resistance and metabolic syndrome. The spectrum of disease ranges from simple steatosis …

Nonalcoholic fatty liver disease (NAFLD) is a very common cause of chronic liver disease in
the United States. A large proportion of patients with NAFLD have coexisting metabolic …

Nonalcoholic fatty liver disease (NAFLD) is an increasingly common condition that is
believed to affect> 25% of adults worldwide. Unless specific testing is done to identify …

Nonalcoholic fatty liver disease (NAFLD), the most common of chronic liver disease in
Western Country, is closely related to insulin resistance and oxidative stress and includes a …

Nonalcoholic fatty liver disease (NAFLD) has emerged as the most frequent cause of liver
disease worldwide, comprising a plethora of conditions, ranging from steatosis to end‐stage …

Non-alcoholic fatty liver DISEASE (NAFLD) is the most common chronic liver disease in
Western countries and affects approximately 25% of the adult population. Since NAFLD is …

Although accumulating evidence points to NAFLD emerging as a novel cardiovascular risk
factor, more research is needed to find suitable noninvasive biomarkers of NAFLD severity …

Non-alcoholic fatty liver disease (NAFLD) is highly prevalent and includes a spectrum of
abnormalities ranging from steatosis to cirrhosis. In this review, we address recent evidence …

Nonalcoholic fatty liver disease (NAFLD) is prevalent in people with the metabolic syndrome
and type 2 diabetes and is present in up to one‐third of the general population. Evidence is …

Nonalcoholic fatty liver disease (NAFLD) is the hepatic component of the metabolic
syndrome. The aim of this review is to summarize the available data linking NAFLD with …